GLOMERULONEPHRITIS
Clinical trials for GLOMERULONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new GLOMERULONEPHRITIS trials appear
Sign up with your email to follow new studies for GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney disease: Long-Term drug safety trial launches
Disease control Recruiting nowThis study looks at the long-term safety of a drug called zigakibart for adults with IgA nephropathy, a kidney disease. It is for people who have already finished another zigakibart study. The goal is to see if the drug remains safe and helpful over time.
Matched conditions: GLOMERULONEPHRITIS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 04:18 UTC
-
Immune cell therapy takes on lupus kidney disease
Disease control Recruiting nowThis study tests a new treatment called NKX019, which uses specially engineered immune cells (CAR NK cells) to target and calm overactive immune cells that attack the kidneys. It is for people with active lupus nephritis or primary membranous nephropathy who have not responded to…
Matched conditions: GLOMERULONEPHRITIS
Phase: PHASE1, PHASE2 • Sponsor: Nkarta, Inc. • Aim: Disease control
Last updated May 17, 2026 04:13 UTC